MENU
ELVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enliven Therapeutics (ELVN) Earnings Date & Reports

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more

A.I. Advisor
published Earnings

ELVN is expected to report earnings to rise 2.18% to -50 cents per share on November 06

Enliven Therapeutics ELVN Stock Earnings Reports
Q3'25
Est.
$-0.50
Q2'25
Beat
by $0.06
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.03
The last earnings report on August 13 showed earnings per share of -49 cents, beating the estimate of -55 cents. With 467.56K shares outstanding, the current market capitalization sits at 1.22B.
View a ticker or compare two or three
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELVN showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
6200 Lookout Road
Phone
+1 720 647-8519
Employees
46
Web
https://www.enliventherapeutics.com